What if late pregnancy fasting glucose can signal late-onset gestational diabetes?

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study screens pregnant people who previously tested negative for GDM or never had GDM, using a fasting blood glucose test at 32–34 weeks to see if fasting glucose ≥92 mg/dL indicates late-onset GDM. It then explores connections between this finding and perinatal and maternal outcomes. The goal is to inform screening practices and recommendations for late-stage gestational diabetes. The study is conducted at Izmir Katip Çelebi Atatürk Training and Research Hospital in Izmir, Turkey. Participation requires consent and follow-up through the postpartum period.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Gestational Age: Confirmed singleton pregnancy between 32+0 and 34+6 weeks of gestation based on the last menstrual period (LMP) and/or first-trimester crown-rump length (CRL) ultrasound measurement.

Follow-up: Intention and willingness to deliver at the study hospital and complete all planned follow-up visits until the end of the postpartum period.

Informed Consent: Voluntary agreement to participate in the study evidenced by signed written informed consent.

Exclusion Criteria:

* Multifetal pregnancies (e.g., twins, triplets) Fetal Anomalies Pre-gestational Chronic Diseases Protocol Non-compliance / Loss to Follow-up Preterm Birth / Preterm Labor

Where it's running

• İzmir Katip Çelebi Atatürk Training and Research
  Izmir, Karabağlar, Turkey (Türkiye) Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Oral Health Care During Pregnancy to Try to Improve Gum Health and Birth Outcomes

  This study tests two noninvasive ways to improve dental health for pregnant people with gum disease, to see if better oral care can help pregnancy outcomes.

  Recruiting University of California, San Francisco · San Francisco, California · NCT07377344

• MI MOM: A web app to support healthy pregnancy and postpartum health

  This study tests whether the MI MOM web app, used with support from friends and family, improves pregnancy and postpartum health for Medicaid-enrolled pregnant people compared to usual care.

  Recruiting at 8 sites Michigan State University · Corunna, Michigan and 7 other locations · NCT07213284

• Evaluating new ultrasound techniques for assessing placental health

  This study is testing new ultrasound techniques to see if they can help tell the difference between healthy pregnancies and those with fetal growth issues.

  Recruiting Carilion Clinic · Roanoke, Virginia · NCT06861309

• Pregnant Women Living with HIV on Bictegravir/Emtricitabine/Tenofovir Alafenamide

  This study looks at how B/F/TAF is used in pregnant women with HIV and whether it helps maintain viral suppression from before conception through delivery.

  Recruiting Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida · Paris · NCT07921472

• Pelvic Floor Training and a Modified Lumbopelvic Belt for Symphysis Pubis Pain in Pregnancy

  This study tests whether pelvic floor muscle training plus a modified lumbopelvic belt can reduce pain and improve function for pregnant women with symphysis pubis pain.

  Recruiting Kahramanmaras Sutcu Imam University · Kahramanmaraş · NCT07919548

• Effective Communication in VBAC Counseling

  This study tests how clearly doctors and midwives explain VBAC options during prenatal visits and whether patients feel understood.

  Recruiting IRCCS San Raffaele · Milan, MI · NCT07919145

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.